Table 1.
HIV-infected (n = 430) | HIV-uninfected (n = 781) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | |||
(n = 101) | (n = 109) | (n = 98) | (n = 114) | P-value | (n = 192) | (n = 186) | (n = 195) | (n = 186) | P-value | |
See text for BMI ranges for Q1 (lowest) to Q4 (highest). | ||||||||||
Unless otherwise noted, continuous variables are expressed in mean (SD). | ||||||||||
BMI, body mass index; USD, US dollar equivalent. | ||||||||||
BMI, mean (SD) | 21.2 (1.2) | 23.6 (0.5) | 25.5 (0.7) | 29.3 (2.4) | - | 21.2 (1.3) | 23.5 (0.5) | 25.6 (0.7) | 29.4 (2.5) | - |
Age, mean (SD) | 24.1 (4.5) | 24.3 (4.7) | 24.9 (5.8) | 25.8 (5.8) | 0.11 | 22.9 (5.8) | 23.2 (5.4) | 23.2 (6.1) | 25.1 (6.3) | <0.0001 |
Weekly income, USD, mean (SD) | 4.72 (10.00) | 4.41 (5.67) | 6.94 (17.74) | 4.96 (4.95) | 0.39 | 3.67 (5.79) | 4.37 (5.17) | 5.91 (9.88) | 6.74 (11.30) | <0.0001 |
Years education, mean (SD) | 6.8 (2.9) | 6.2 (2.9) | 6.7 (2.8) | 7.1 (2.6) | 0.13 | 6.4 (3.0) | 6.5 (2.9) | 7.1 (2.8) | 6.8 (2.9) | 0.14 |
Parity, mean (SD) | 1.5 (1.3) | 1.9 (1.4) | 2.0 (1.6) | 2.2 (1.8) | 0.01 | 1.4 (1.5) | 1.5 (1.6) | 1.8 (1.9) | 2.1 (2.0) | <0.0001 |
% married | 90.1% | 94.5% | 91.8% | 93.9% | 0.45 | 93.2% | 93.0% | 93.3% | 94.6% | 0.57 |
% breast-feeding | 95.2% | 97.9% | 94.9% | 97.8% | 0.56 | 96.0% | 97.2% | 98.0% | 96.9% | 0.57 |
% prior stillbirth | 4.0% | 8.3% | 12.2% | 12.3% | 0.02 | 9.3% | 7.0% | 8.7% | 6.4% | 0.42 |
CD4 count | 355 (198) | 370 (213) | 392 (212) | 377 (206) | 0.66 | - | - | - | - | - |
% CD4 <200 | 22.8% | 21.1% | 14.7% | 21.2% | 0.57 | - | - | - | - | - |
Log10 viral load | 5.04 (4.87) | 4.87 (5.08) | 4.91 (5.18) | 4.85 (5.27) | 0.47 | - | - | - | - | - |
% adherent to nevirapine | 63.4% | 69.7% | 66.3% | 67.3% | 0.66 | - | - | - | - | - |